...
首页> 外文期刊>The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition >Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial.
【24h】

Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial.

机译:Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial.

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Consumption of liquid calories from beverages has increased in parallel with the obesity epidemic in the US population, but their causal relation remains unclear. OBJECTIVE: The objective of this study was to examine how changes in beverage consumption affect weight change among adults. DESIGN: This was a prospective study of 810 adults participating in the PREMIER trial, an 18-mo randomized, controlled, behavioral intervention trial. Measurements (weight, height, and 24-h dietary recall) were made at baseline, 6 mo, and 18 mo. RESULTS: Baseline mean intake of liquid calories was 356 kcal/d (19 of total energy intake). After potential confounders and intervention assignment were controlled for, a reduction in liquid calorie intake of 100 kcal/d was associated with a weight loss of 0.25 kg (95 CI: 0.11, 0.39; P < 0.001) at 6 mo and of 0.24 kg (95 CI: 0.06, 0.41; P = 0.008) at 18 mo. A reduction in liquid calorie intake had a stronger effect than did a reduction in solid calorie intake on weight loss. Of the individual beverages, only intake of sugar-sweetened beverages (SSBs) was significantly associated with weight change. A reduction in SSB intake of 1 serving/d was associated with a weight loss of 0.49 kg (95 CI: 0.11, 0.82; P = 0.006) at 6 mo and of 0.65 kg (95 CI: 0.22, 1.09; P = 0.003) at 18 mo. CONCLUSIONS: These data support recommendations to limit liquid calorie intake among adults and to reduce SSB consumption as a means to accomplish weight loss or avoid excess weight gain. This trial was registered at clinicaltrials.gov as NCT00000616.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号